BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19788695)

  • 1. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection.
    Abe H; Ochi H; Maekawa T; Hatakeyama T; Tsuge M; Kitamura S; Kimura T; Miki D; Mitsui F; Hiraga N; Imamura M; Fujimoto Y; Takahashi S; Nakamura Y; Kumada H; Chayama K
    Hepatol Res; 2009 Dec; 39(12):1159-68. PubMed ID: 19788695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation.
    Pan JW; Zabidi MMA; Chong BK; Meng MY; Ng PS; Hasan SN; Sandey B; Bahnu S; Rajadurai P; Yip CH; Rueda OM; Caldas C; Chin SF; Teo SH
    Int J Cancer; 2021 May; 148(10):2489-2501. PubMed ID: 33423300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.
    Zhang T; Cai J; Chang J; Yu D; Wu C; Yan T; Zhai K; Bi X; Zhao H; Xu J; Tan W; Qu C; Lin D
    Hum Mol Genet; 2013 Mar; 22(6):1262-9. PubMed ID: 23213177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p.
    Faure-Dupuy S; Riedl T; Rolland M; Hizir Z; Reisinger F; Neuhaus K; Schuehle S; Remouchamps C; Gillet N; Schönung M; Stadler M; Wettengel J; Barnault R; Parent R; Schuster LC; Farhat R; Prokosch S; Leuchtenberger C; Öllinger R; Engleitner T; Rippe K; Rad R; Unger K; Tscharahganeh D; Lipka DB; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwälder M
    JHEP Rep; 2021 Dec; 3(6):100354. PubMed ID: 34704004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
    Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
    J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    Kim YS; Sun S; Yoon JS; Ko YH; Won HS; Kim JS
    PLoS One; 2020; 15(3):e0230261. PubMed ID: 32176735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
    Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
    Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.
    Perez-Bercoff D; Laude H; Lemaire M; Hunewald O; Thiers V; Vignuzzi M; Blanc H; Poli A; Amoura Z; Caval V; Suspène R; Hafezi F; Mathian A; Vartanian JP; Wain-Hobson S
    Sci Rep; 2021 Apr; 11(1):7893. PubMed ID: 33846459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
    Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
    bioRxiv; 2023 Aug; ():. PubMed ID: 37577595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.
    Zhang W; Zhang X; Tian C; Wang T; Sarkis PT; Fang Y; Zheng S; Yu XF; Xu R
    Cell Microbiol; 2008 Jan; 10(1):112-21. PubMed ID: 17672864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer.
    Papini C; Wang Z; Kudalkar SN; Schrank TP; Tang S; Sasaki T; Wu C; Tejada B; Ziegler SJ; Xiong Y; Issaeva N; Yarbrough WG; Anderson KS
    iScience; 2022 Oct; 25(10):105077. PubMed ID: 36164654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection.
    Noguchi C; Imamura M; Tsuge M; Hiraga N; Mori N; Miki D; Kimura T; Takahashi S; Fujimoto Y; Ochi H; Abe H; Maekawa T; Tateno C; Yoshizato K; Chayama K
    J Infect Dis; 2009 Jun; 199(11):1599-607. PubMed ID: 19432545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
    Goila-Gaur R; Khan MA; Miyagi E; Kao S; Strebel K
    Retrovirology; 2007 Aug; 4():61. PubMed ID: 17727729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AID, APOBEC3A and APOBEC3B efficiently deaminate deoxycytidines neighboring DNA damage induced by oxidation or alkylation.
    Diamond CP; Im J; Button EA; Huebert DNG; King JJ; Borzooee F; Abdouni HS; Bacque L; McCarthy E; Fifield H; Berghuis LM; Larijani M
    Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129415. PubMed ID: 31404619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.
    Wang Y; Li X; Song S; Sun Y; Zhang J; Yu C; Chen W
    Virol J; 2017 Nov; 14(1):211. PubMed ID: 29100527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection.
    Meier MA; Suslov A; Ketterer S; Heim MH; Wieland SF
    J Viral Hepat; 2017 Aug; 24(8):662-671. PubMed ID: 28182305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
    Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
    Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G to A hypermutation of hepatitis B virus.
    Noguchi C; Ishino H; Tsuge M; Fujimoto Y; Imamura M; Takahashi S; Chayama K
    Hepatology; 2005 Mar; 41(3):626-33. PubMed ID: 15726649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.